Tuoxin Pharmaceutical Group Co.,Ltd. (SHE:301089)
23.20
+0.50 (2.20%)
At close: Jul 3, 2026
SHE:301089 Market Cap
SHE:301089 has a market cap or net worth of 2.94 billion as of July 2, 2026. Its market cap has decreased by -28.37% in one year.
Market Cap
2.94B
Enterprise Value
2.71B
Revenue
373.85M
Ranking
n/a
PE Ratio
n/a
Stock Price
23.20
Market Cap Chart
Since October 27, 2021, SHE:301089's market cap has decreased from 3.63B to 2.94B, a decrease of -19.15%. That is a compound annual growth rate of -4.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2026 | 2.94B | -17.14% |
| Dec 31, 2025 | 3.54B | -0.67% |
| Dec 31, 2024 | 3.57B | -47.81% |
| Dec 29, 2023 | 6.83B | -24.66% |
| Dec 30, 2022 | 9.07B | -10.45% |
| Dec 31, 2021 | 10.13B | 178.97% |
| Oct 27, 2021 | 3.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PKU HealthCare Corp.,Ltd. | 3.09B |
| Huaren Pharmaceutical | 3.07B |
| Qianjiang Yongan Pharmaceutical | 3.07B |
| Harbin Medisan Pharmaceutical | 3.06B |
| Baotou Dongbao Bio-Tech Co.,Ltd | 3.04B |
| Qinghai Spring Medicinal Resources Technology | 2.96B |
| Hunan Hansen Pharmaceutical | 2.94B |
| Honz Pharmaceutical | 2.91B |